ORIENT BIO Inc.

KOSE:A002630 Stock Report

Market Cap: ₩56.9b

ORIENT BIO Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Jae-Jin Chang

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership0.8%
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

Would ORIENT BIO (KRX:002630) Be Better Off With Less Debt?

May 01
Would ORIENT BIO (KRX:002630) Be Better Off With Less Debt?

Is ORIENT BIO (KRX:002630) Weighed On By Its Debt Load?

Jan 16
Is ORIENT BIO (KRX:002630) Weighed On By Its Debt Load?

CEO

Jae-Jin Chang (63 yo)

no data

Tenure

Mr. Jae-Jin Chang serves as the Chief Executive Officer of Bio Genomics, Inc. Mr. Chang serves as President, Chief Executive Officer and Chairperson of ORIENT BIO Inc. He completed graduate studies at Konk...